BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatr Dis Treat 2019;15:2559-69. [PMID: 31564881 DOI: 10.2147/NDT.S209284] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Andrusenko I, Potticary J, Hall SR, Gemmi M. A new olanzapine cocrystal obtained from volatile deep eutectic solvents and determined by 3D electron diffraction. Acta Crystallogr B Struct Sci Cryst Eng Mater 2020;76:1036-44. [PMID: 33289715 DOI: 10.1107/S2052520620012779] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Faden J, Serdenes R, Citrome L. Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used? Expert Rev Neurother 2022. [PMID: 35354374 DOI: 10.1080/14737175.2022.2060742] [Reference Citation Analysis]
3 Pahwa M, Sleem A, Elsayed OH, Good ME, El-Mallakh RS. New Antipsychotic Medications in the Last Decade. Curr Psychiatry Rep 2021;23:87. [PMID: 34843030 DOI: 10.1007/s11920-021-01298-w] [Reference Citation Analysis]
4 Skryabin VY, Zastrozhin M, Sychev DA. Olanzapine-Associated Rhabdomyolysis: A Case Report. Cureus 2021;13:e12568. [PMID: 33564555 DOI: 10.7759/cureus.12568] [Reference Citation Analysis]
5 Keating D, McWilliams S, Boland F, Doyle R, Behan C, Strawbridge J, Clarke M. Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study. BMJ Open 2021;11:e040387. [PMID: 33518516 DOI: 10.1136/bmjopen-2020-040387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Baldwin DS. The first patient to receive olanzapine: A recollection. Hum Psychopharmacol 2021;36:e2823. [PMID: 34699631 DOI: 10.1002/hup.2823] [Reference Citation Analysis]
7 Fitzgerald I, O'Dwyer S, Brooks M, Sahm L, Crowley E, Ní Dhubhlaing C. Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine. Front Psychiatry 2021;12:730769. [PMID: 34557121 DOI: 10.3389/fpsyt.2021.730769] [Reference Citation Analysis]
8 Ashraf GM, Alghamdi BS, Alshehri FS, Alam MZ, Tayeb HO, Tarazi FI. Empagliflozin Effectively Attenuates Olanzapine-Induced Body Weight Gain in Female Wistar Rats. Front Pharmacol 2021;12:578716. [PMID: 33953666 DOI: 10.3389/fphar.2021.578716] [Reference Citation Analysis]
9 Jo YT, Joo SW, Ahn S, Choi Y, Lee J. Use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study. BJPsych Open 2021;7:e142. [PMID: 34342261 DOI: 10.1192/bjo.2021.964] [Reference Citation Analysis]
10 Citrome L, Graham C, Simmons A, Jiang Y, Todtenkopf MS, Silverman B, DiPetrillo L, Cummings H, Sun L, McDonnell D. An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder. Neuropsychiatr Dis Treat 2021;17:2885-904. [PMID: 34526769 DOI: 10.2147/NDT.S313840] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zapata RC, Chaudry BS, Valencia ML, Zhang D, Ochsner SA, McKenna NJ, Osborn O. Conserved immunomodulatory transcriptional networks underlie antipsychotic-induced weight gain. Transl Psychiatry 2021;11:405. [PMID: 34294678 DOI: 10.1038/s41398-021-01528-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Tachi K, Fukuda T, Tanaka M. Olanzapine attenuates postoperative cognitive dysfunction in adult rats. Heliyon 2021;7:e06218. [PMID: 33659744 DOI: 10.1016/j.heliyon.2021.e06218] [Reference Citation Analysis]